Andersons pediatric cardiology 2378
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (81.46 KB, 3 trang )
Respiratorygases,exchangeof,analysersof,forexercisetesting,389,390f
Respiratorymanagement,forpulmonaryhypertension,205–206,206f
Respiratorymuscleenergetics,1290
Restrictedorduct-dependentpulmonarybloodflow,1278–1280,1278f–1279f
decisionmakingin,1279
surgicaltechniquefor,1279–1280
Restrictedorduct-dependentsystemicbloodflow,1280–1284
decisionmakingin,1280–1281,1281f–1282f
surgicaltechniquefor,1281–1284,1283f
Restrictivecardiomyopathy,1146b,1159–1161
cardiaccatheterizationin,1161
cardiopulmonaryexercisetestingin,1161
chestradiographyin,1160
clinicalfeaturesof,1160–1161
clinicaloutcomesof,1159
definitionof,1159
echocardiographyin,1160–1161,1161f
electrocardiographyin,1160,1160f
ambulatory,1160
endomyocardialfibrosisand,1159
eosinophilic,1159
epidemiologyof,1159
etiologyof,1159–1160
idiopathic,1159
managementof,1161
pathologyof,1160
pathophysiologyof,1160
pericardialconstrictionand,1072,1073t
Restrictivelungdisease,inFontancirculation,1322–1323
Resuscitationgas,inextremelyprematureneonate,191
Retransplantation,incardiactransplantation,1476
Retro-aorticbrachiocephalicvein,469,469f
REVprocedure,690–692,691f
Revascularization,forKawasakisyndrome,991–992
Reverberations,onultrasoundimages,283
Reyesyndrome,989
Rhabdomyomas,cardiac,968–971,970f
Rheumaticfever,acute,997–1021
cellularresponseand,1002
clinicalmanifestationsof,1004–1007,1006f,1006t
carditisas,1007–1009,1007b
erythemamarginatumas,1010–1011,1011f
minor,1011
polyarthritisas,1009
subcutaneousnodulesas,1010,1010f–1011f
Sydenhamchoreaas,1009–1010
valvitisas,subclinical,1008–1009,1008b
diagnosisof,difficultieswith,1011–1012
epidemiologyof,998–999,999f
etiologyandpathogenesisof,999–1000
historicalbackgroundof,997–998
humanleukocyteantigenassociatedwith,1001,1001t
humoralresponseand,1001–1002,1002f
interactionbetweenhostandpathogensin,1001
laboratoryinvestigationsin,1012–1015
acute-phasereactantsin,1013
echocardiographyin,1014–1015,1014f–1015f
toevaluatecardiacinvolvement,1013–1014
supportingevidenceofrecentgroupAstreptococcalinfectionand,1012–1013
managementof,1015–1018
ofclinicalmanifestations,1016–1018
eradicationofgroupAstreptococcalinfectionand,1016,1016t
morphologyofacutecardiacandextra-cardiaclesionsin,1002–1004,1003f–1005f
preventionof,1018–1021
primary,1018–1019,1018b
primordial,1018
secondary,1020–1021,1020t–1021t
vaccinedevelopmentfor,1002
Streptococcusand,1000–1001,1000f
Rheumaticheartdisease,1522
chronic,1023–1041
backgroundandepidemiologyof,1023,1024f
cardiacmagneticresonanceimagingin,1031–1032
chronicprogression,1026
clinicalassessmentof,1026–1027
complicationsof,1032
diagnosticcriteriafor,1023–1026
insettingofdocumentedepisodeofARF,1024,1025b
withoutprevioushistoryofARF,1026
echocardiographicscreeningof,1038–1039
echocardiographyand,1027–1031
aorticvalvedisease,1027–1030,1030b,1031f
cardiosurgicalintervention,1031,1032f
mitralvalvedisease,1027,1028f–1030f,1028b
progression/resolutionmonitoring,1031
pulmonaryvalvedisease,1030
tricuspidvalvedisease,1030
valvularseveritygrading,1030–1031
establishingcentersfor,1039–1041,1041b
managementof
medical,1032–1034
percutaneousstrategiesfor,1034–1036
surgeryfor,1036–1037,1037t
pathogenesisof,1023,1025f
globalburdenof,1520
Rhythmdisturbances,inmodifiedFontanprocedure,1304
Rhythmstrips,inarrhythmia,357
Rifampicin
forbloodculture-negativeendocarditis,1054t
forinfectiveendocarditis,1053t
Rightaorticarch
withaberrantleftsubclavianartery,878–880,881f–882f
surgicaltechniquesfor,895,895f
withaberrantoriginoftheleftbrachiocephalicartery,878–880
withamirror-imagebranching,880,884f–885f
Rightatrialappendage,indiagnosticcatheterization,245
Rightatrium
